Skip to content

Symptom investigation and analysis of influencing factors after thoracoscopic lung cancer surgery: a multi-center prospective observational study

Symptom investigation and analysis of influencing factors after thoracoscopic lung cancer surgery: a multi-center prospective observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046629
Enrollment
Unknown
Registered
2021-05-23
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Observation group:N/A

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who intend to undergo pulmonary VATS; 2. Pathological diagnosis of primary lung cancer before or after surgery; 3. Clear consciousness and barrier-free language communication; 4. Voluntary participation in investigations and research.

Exclusion criteria

Exclusion criteria: 1. Existence of mental illness; 2. Patients who converted to thoracotomy during the operation; 3. Combined with other serious diseases or other cancers, and need treatment.

Design outcomes

Primary

MeasureTime frame
Postoperative symptoms (cough, pain, shortness of breath, fatigue, dizziness, nausea and vomiting, subcutaneous emphysema, insomnia, constipation);Surgery-related information (method of operation, scope of resection, operation time, time of anesthesia, application of urinary catheter, chest tube guide, analgesic method, postoperative pathological staging);

Secondary

MeasureTime frame
Demographic data (age, gender, marital status, occupation, smoking history);

Countries

China

Contacts

Public ContactChe Guowei

West China Hospital, Sichuan University

guowei_che@yahoo.com+86 18980601890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026